Radiotherapy for prostate cancer does NOT increase risk for MDS

For many years there has been an assumption that men treated for prostate cancer with radiation therapy were at increased risk for a subsequent diagnosis with myelodyspastic syndrome (MDS) as they grew older. … READ MORE …

Managing metabolic syndrome in men at risk for progressive prostate cancer

Over a month ago we reported on a paper by Häggström et al. that noted an increased risk of death among patients with prostate cancer and metabolic syndrome. … READ MORE …

Metabolic syndrome and risk for prostate cancer-specific mortality

According to an article due to be published on line today in Cancer,  a group of clinical characteristics commonly referred to as “metabolic syndrome” are strongly associated with an increased risk for prostate cancer-specific mortality among men diagnosed with prostate cancer, but are not associated with an increased risk for the initial diagnosis. … READ MORE …